| Association of survival and immune-related biomarkers with immunotherapy in patients with non–small cell lung cancer: A meta-analysis and individual patient–level analysis Y Yu, D Zeng, Q Ou, S Liu, A Li, Y Chen, D Lin, Q Gao, H Zhou, W Liao, ... JAMA network open 2 (7), e196879-e196879, 2019 | 210 | 2019 |
| Prognostic and predictive value of tumor-infiltrating lymphocytes for clinical therapeutic research in patients with non-small cell lung cancer DQ Zeng, YF Yu, QY Ou, XY Li, RZ Zhong, CM Xie, QG Hu Oncotarget 7 (12), 13765, 2016 | 206 | 2016 |
| Gene expression profiles for a prognostic immunoscore in gastric cancer D Zeng, R Zhou, Y Yu, Y Luo, J Zhang, H Sun, J Bin, Y Liao, J Rao, ... Journal of British Surgery 105 (10), 1338-1348, 2018 | 194 | 2018 |
| Development and validation of a preoperative magnetic resonance imaging radiomics–based signature to predict axillary lymph node metastasis and disease-free survival in … Y Yu, Y Tan, C Xie, Q Hu, J Ouyang, Y Chen, Y Gu, A Li, N Lu, Z He, ... JAMA network open 3 (12), e2028086-e2028086, 2020 | 182 | 2020 |
| Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in … Y Yu, Z He, J Ouyang, Y Tan, Y Chen, Y Gu, L Mao, W Ren, J Wang, L Lin, ... EBioMedicine 69, 2021 | 145 | 2021 |
| Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer D Zeng, J Wu, H Luo, Y Li, J Xiao, J Peng, Z Ye, R Zhou, Y Yu, G Wang, ... Journal for immunotherapy of cancer 9 (8), 2021 | 128 | 2021 |
| Association of long noncoding RNA biomarkers with clinical immune subtype and prediction of immunotherapy response in patients with cancer Y Yu, W Zhang, A Li, Y Chen, Q Ou, Z He, Y Zhang, R Liu, H Yao, E Song JAMA Network open 3 (4), e202149-e202149, 2020 | 79 | 2020 |
| Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning … L Huang, W Lin, D Xie, Y Yu, H Cao, G Liao, S Wu, L Yao, Z Wang, ... European Radiology, 1-14, 2022 | 33 | 2022 |
| Prognostic and immunological role of CD36: A pan-cancer analysis YJ Chen, WX Liao, SZ Huang, YF Yu, JY Wen, J Chen, DG Lin, XY Wu, ... Journal of Cancer 12 (16), 4762, 2021 | 27 | 2021 |
| A prognostic risk score based on hypoxia-, immunity-, and epithelialto-mesenchymal transition-related genes for the prognosis and immunotherapy response of lung adenocarcinoma W Ouyang, Y Jiang, S Bu, T Tang, L Huang, M Chen, Y Tan, Q Ou, L Mao, ... Frontiers in Cell and Developmental Biology 9, 758777, 2022 | 26 | 2022 |
| LncRNA Uc003xsl. 1-mediated activation of the NFκB/IL8 axis promotes progression of triple-negative breast cancer Y Xu, W Ren, Q Li, C Duan, X Lin, Z Bi, K You, Q Hu, N Xie, Y Yu, X Xu, ... Cancer research 82 (4), 556-570, 2022 | 23 | 2022 |
| Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study) HY Zhou, SP Zheng, AL Li, QL Gao, QY Ou, YJ Chen, ST Wu, DG Lin, ... EClinicalMedicine 24, 2020 | 23 | 2020 |
| Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma Q Ou, Y Yu, A Li, J Chen, T Yu, X Xu, X Xie, Y Chen, D Lin, Q Zeng, ... Annals of Translational Medicine 8 (5), 2020 | 20 | 2020 |
| Clinical evidence for locoregional surgery of the primary tumor in patients with de novo stage IV breast cancer Y Yu, H Hong, Y Wang, T Fu, Y Chen, J Zhao, P Chen, R Cai, Y Tan, Z He, ... Annals of Surgical Oncology, 1-12, 2021 | 17 | 2021 |
| Efficacy and safety of cyclin-dependent kinases 4 and 6 inhibitors in HR+/HER2− advanced breast cancer N Xie, T Qin, W Ren, H Yao, Y Yu, H Hong Cancer Management and Research, 4241-4250, 2020 | 17 | 2020 |
| Association of immune checkpoint inhibitor therapy with survival in patients with cancers with MUC16 variants Y Yu, D Lin, A Li, Y Chen, Q Ou, H Hu, H Yao JAMA Network Open 3 (6), e205837-e205837, 2020 | 16 | 2020 |
| A noninvasive tool based on magnetic resonance imaging radiomics for the preoperative prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer C Li, N Lu, Z He, Y Tan, Y Liu, Y Chen, Z Wu, J Liu, W Ren, L Mao, Y Yu, ... Annals of Surgical Oncology 29 (12), 7685-7693, 2022 | 15 | 2022 |
| KEAP1/NFE2L2 mutations of liquid biopsy as prognostic biomarkers in patients with advanced non-small cell lung cancer: results from two multicenter, randomized clinical trials H Zhu, D Xie, Y Yu, L Yao, B Xu, L Huang, S Wu, F Li, Y Zheng, X Liu, ... Frontiers in oncology 11, 659200, 2021 | 15 | 2021 |
| Deep learning magnetic resonance imaging predicts platinum sensitivity in patients with epithelial ovarian cancer R Lei, Y Yu, Q Li, Q Yao, J Wang, M Gao, Z Wu, W Ren, Y Tan, B Zhang, ... Frontiers in Oncology 12, 895177, 2022 | 10 | 2022 |
| Prognostic immune-related gene models for breast cancer: a pooled analysis J Zhao, Y Wang, Z Lao, S Liang, J Hou, Y Yu, H Yao, N You, K Chen OncoTargets and therapy, 4423-4433, 2017 | 9 | 2017 |
